<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Proportions of <z:chebi fb="2" ids="27208">unsaturated fatty acids</z:chebi> of <z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) <z:chebi fb="23" ids="18059">lipids</z:chebi> and their relationships to the <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> level were compared in hypo- and hyperalphalipoproteinemic subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Both groups did not differ in the level of serum cholesterol </plain></SENT>
<SENT sid="2" pm="."><plain>However, <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> was associated with <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, higher <z:chebi fb="17" ids="39025">HDL</z:chebi>-triacylglycerol level, and higher proportion of <z:chebi fb="17" ids="39025">HDL</z:chebi>-18:1 (<z:chebi fb="0" ids="16196">oleic acid</z:chebi>) and lower proportions of <z:chebi fb="17" ids="39025">HDL</z:chebi>-18:2 (<z:chebi fb="0" ids="17351">linoleic acid</z:chebi>) and 20:4 (<z:chebi fb="0" ids="15843">arachidonic acid</z:chebi>) than <z:e sem="disease" ids="C0342883" disease_type="Disease or Syndrome" abbrv="">hyperalphalipoproteinemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="17" ids="39025">HDL</z:chebi>-20:4 was the only fatty acid correlating (negatively) with <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>However, <z:chebi fb="17" ids="39025">HDL</z:chebi>-18:1 correlated positively and <z:chebi fb="17" ids="39025">HDL</z:chebi>-18:2 negatively with <z:chebi fb="17" ids="39025">HDL</z:chebi>-<z:chebi fb="0" ids="17855">triacylglycerols</z:chebi>, <z:chebi fb="23" ids="18059">lipids</z:chebi> related to the fall of <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>These results suggest 1) an antagonism of 20:4 and 18:2 as structural components of <z:chebi fb="17" ids="39025">HDL</z:chebi> <z:chebi fb="23" ids="18059">lipids</z:chebi> in relation to the <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> level, and 2) an association of replacement of <z:chebi fb="17" ids="39025">HDL</z:chebi> 18:2 by 18:1 with the disorder of plasma triacylglycerol metabolism </plain></SENT>
</text></document>